Article preview reprinted from Start-Up - March, 2009
AeonClad Biomedical 's AeonCoat coating technology allows for surface modification at the nanoscale or particle level.
AeonClad Biomedical LLC
Article preview reprinted from Start-Up - March, 2009
The dry, tunabe coating process can precisely apply a coating as thin as a few nanometers to as thick as hundreds of microns to a medical device or a drug powder. For devices, the start-up will create lubricious coatings for easier insertion and placement, coatings to increase cell growth and adhesion, non-fouling coatings that prevent contaminants from forming, and functional coatings for convenient attachment of biological materials. For drug delivery, AeonClad is focused on improving the efficacy of poorly water soluble drugs by preventing the drug from clumping once ingested and increasing the rate at which the drug dissolves in water.
Purchase this article online as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed. Subscribe to Start-Up.
Companies mentioned in this article:
AeonClad Biomedical LLC
Elan Corp. PLC
University of Texas
START-UP: No publication reviews leading edge companies and technology better than START-UP. Each issue of START-UP profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics. Subscribe to START-UP.
